Document Detail


The spectrum of kidney involvement in lymphoma: a case report and review of the literature.
MedLine Citation:
PMID:  20843590     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Kidney involvement is an under-recognized complication of both Hodgkin and non-Hodgkin lymphoma. The diversity of lymphoma-related renal manifestations makes diagnosis difficult. Although abrupt worsening of kidney function may be the first sign of malignant disease, renal effects can be subtle or even silent. The causes of renal involvement similarly are varied. We discuss a case of non-Hodgkin lymphoma and associated kidney failure from several distinct malignancy-related mechanisms and review the spectrum of lymphoma-related kidney involvement.
Authors:
Lisa J Cohen; Helmut G Rennke; Jacob P Laubach; Benjamin D Humphreys
Publication Detail:
Type:  Case Reports; Journal Article; Research Support, N.I.H., Extramural; Review     Date:  2010-09-16
Journal Detail:
Title:  American journal of kidney diseases : the official journal of the National Kidney Foundation     Volume:  56     ISSN:  1523-6838     ISO Abbreviation:  Am. J. Kidney Dis.     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2010-11-24     Completed Date:  2010-12-16     Revised Date:  2014-09-21    
Medline Journal Info:
Nlm Unique ID:  8110075     Medline TA:  Am J Kidney Dis     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1191-6     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Antibodies, Monoclonal, Murine-Derived / therapeutic use
Antineoplastic Agents / therapeutic use
Boronic Acids / therapeutic use
Dexamethasone / therapeutic use
Drug Therapy, Combination
Humans
Kidney / pathology,  physiopathology*
Lymphoma, Non-Hodgkin / complications*,  drug therapy,  physiopathology*
Male
Prognosis
Pyrazines / therapeutic use
Renal Insufficiency / diagnosis,  etiology*,  physiopathology*
Treatment Outcome
Grant Support
ID/Acronym/Agency:
DK073628/DK/NIDDK NIH HHS; DK084316/DK/NIDDK NIH HHS; K08 DK073628/DK/NIDDK NIH HHS; K08 DK073628-04/DK/NIDDK NIH HHS; K08 DK073628-05/DK/NIDDK NIH HHS; R03 DK084316/DK/NIDDK NIH HHS; R03 DK084316-01/DK/NIDDK NIH HHS; T32 DK007527/DK/NIDDK NIH HHS
Chemical
Reg. No./Substance:
0/Antibodies, Monoclonal, Murine-Derived; 0/Antineoplastic Agents; 0/Boronic Acids; 0/Pyrazines; 0/bortezomib; 0/rituximab; 7S5I7G3JQL/Dexamethasone
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The effects of plantar fasciitis and pain on plantar pressure distribution of recreational runners.
Next Document:  The role of endothelial cell injury in thrombotic microangiopathy.